News coverage of FDA warnings on pediatric antidepressant use and suicidality.
News coverage of FDA warnings on pediatric antidepressant use and suicidality.
复制标题
DOI:
10.1542/peds.2009-0792
复制
发表时间:
2010-01
期刊:
影响因子:
8
通讯作者:
Busch SH
中科院分区:
文献类型:
--
作者:
Barry CL;Busch SH
In 2004, after an 18-month investigation, the Food and Drug Administration (FDA) directed pharmaceutical manufacturers to add a black box warning to antidepressants regarding an increased risk of suicidality in children. It has been suggested that news media reporting played a critical role in the sharp declines in pediatric antidepressant use that occurred concurrent with this investigation. Our objective was to evaluate the quality, content and overall impression conveyed in news coverage of this issue. We collected all news stories on pediatric antidepressant use and suicidality published in a convenience sample of 10 of the highest circulation print newspapers in the U.S., the three major television networks and a major cable news network in 2003 and 2004 (N=167). Two researchers coded news articles using a nine-item instrument. Item inter-rater reliability was .84 or greater. The quality of news reporting on key health messages included in FDA warnings was mixed. The overwhelming majority of news stories correctly described a risk of suicidality associated with pediatric antidepressant use as opposed to suicide itself. However, other key health messages highlighted in FDA warnings were often absent from news coverage. In terms of content, news stories, in particular television news, were more likely to include anecdotes of children harmed versus children helped by antidepressants while expert sources quoted were more likely to emphasize the benefits of antidepressants over their risks. However, the majority of news stories conveyed neither the overall impression that the risks of pediatric antidepressant use outweighed the benefits nor that the benefits outweighed the risks, and coverage became increasingly neutral over time. Including key health messages in FDA safety warnings was not sufficient to ensure their communication to the public via the lay press, even though this information might have mitigated risks of pediatric antidepressant use.
登录
查看更多内容
影响因子:
3.8
作者:
Ludwig, J;Marcotte, DE
通讯作者:
Marcotte, DE
影响因子:
120.7
作者:
Schwartz, LM;Woloshin, S
通讯作者:
Woloshin, S
影响因子:
--
作者:
Olfson, Mark;Marcus, Steven C.;Druss, Benjamin G.
通讯作者:
Druss, Benjamin G.
影响因子:
6.6
作者:
Ohberg, A;Vuori, E;Lonnqvist, J
通讯作者:
Lonnqvist, J
影响因子:
158.5
作者:
Kessler, RC;Demler, O;Zaslavsky, AM
通讯作者:
Zaslavsky, AM